Search Results for "Avesthagen Limited Cosmosid"

20:34 EDT 30th August 2015 | BioPortfolio

Matching Channels

None

Matching News

Avesthagen to introduce migraine gene therapy with Australian technology

Biospectrum Severe sufferers of migraine could get some relief with Avesthagen in licensing a gene-based solution devel...

Australia-India collaboration aims to make migraine therapy a reality

(Queensland University of Technology) A collaboration between QUT (Queensland University of Technology) and Indian life science company, Avesthagen Limited, is paving the way for migraine genetics res...

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-05-28. This 151-p...

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-05-28. This 235-page rep...

Biosimilars in Emerging Markets

Recently added to the BioPortfolio report store, Biosimilars in Emerging Markets is a new report from Firstword published on 2015-04-26. This 226-page report is available from $665. What are the imp...

Chemotherapy Induced Anemia - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Chemotherapy Induced Anemia - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-17. This 54-page report is avai...

Psoriatic Arthritis - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Psoriatic Arthritis - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-05-28. This 190-page report is available i...

U.S. Biosimilars Market Worth $11Bn by 2020 - 22% CAGR Forecast for Global Biosimilar Industry in New Research Reports

CHICAGO, August 13, 2015 /PRNewswire/ -- The Global & USA Biosimilar Market Analysis to 2021 research report indicates a high market potential for biosimilars by 2019 when 50% of the biologics ma...

Matching PubMed Articles

None

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement